Anti-C3/C3b/iC3b Purified

Anti-C3/C3b/iC3b Purified
Regulatory status
RUO
Antigen
C3/C3b/iC3b
Clone
6C9
Format
Purified
Reactivity
Mouse, Non-human primates, Human
Variant
0.1 mg
11-949-C100
In stock
203.50 USD
Variant
0.1 mg
11-949-C100
In stock
203.50 USD
Product details
Description
Images
References
SDS download
Isotype
Mouse IgG1 kappa
Specificity
The mouse monoclonal antibody 6C9 recognizes complement components C3, C3b, and iC3b. It does not cross-react with C3d.
Application details
Flow cytometry: Recommended dilution: 0.5-4 μg/ml.
Reactivity
Mouse, Non-human primates, Human
Immunogen
human complement component C3
Concentration
1 mg/ml
Preparation
Purified by protein-A affinity chromatography.
Formulation
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Storage and handling
Store at 2-8°C. Do not freeze.
Exbio licence note
The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.
Other names
complement component C3, complement component C3b, complement component iC3b
Antigen description
Complement component C3 plays a key role in the activation of complement system. In classical complement system pathway the activated C2 and C4 form classical C3-convertase (C4b2b) which cleaves C3 into C3a and C3b. In alternative complement system pathway C3 is cleaved by alternative C3-convertase (C3bBb), composed of C3b (which can be generated also by spontaneous hydrolysis of C3) and the activated form of factor B. C3b activates downstream cascade leading to formation of pores in the plasma membrane of attacked cell. C3b and its proteolytically inactive form iC3b also serve as important opsonins. C3b can generate C3f, as well as the iC3b can be further cleaved into C3c, C3d and C3g. Complement system is regulated by effective inactivation of free C3b by factor H and factor I. C3b attached to the surface of its target is protected from this inactivation. Complement system is also regulated by other proteins, e.g. CD35, CD46, CD55, or CD59. Undesired activation of complement cascade can lead to severe diseases such as PNH, rheumatoid arthritis, macular degeneration and other. Recently it has been demonstrated to take part in complications associated with Covid-19.
Entrez Gene ID 718
UniProt ID P01024
11-949_FC_Profil Značení
Flow cytometry surface staining pattern of human stimulated (PMA + Ionomycin) peripheral blood mononuclear cells stained using anti-human C3/C3b/iC3b (6C9) purified antibody (concentration in sample 0.5 μg/ml) GAM APC.
11-949_FC_Histogram
Separation of human lymphocytes stained using anti-human C3/C3b/iC3b (6C9) purified antibody (concentration in sample 0.5 μg/ml, GAM APC, red-filled) from lymphocytes stained using mouse IgG1 isotype control (MOPC-21) purified antibody (concentration in sample 0.5 μg/ml, same as C3b/iC3b purified concentration, GAM APC, black-dashed) in flow cytometry analysis (surface staining) of human stimulated (PMA + Ionomycin) peripheral blood mononuclear cell suspension.

Product specific references:

Sun Y, Xu B, Zhuge X, Tang F, Wang X, Gong Q, Chen R, Xue F, Dai J: Factor H is bound by outer membrane-displayed carbohydrate metabolism enzymes of extraintestinal pathogenic Escherichia coli and contributes to opsonophagocytosis resistance in bacteria. Front Cell Infect Microbiol. 2021 Jan 25:10:592906.
PubMed
Shi J, Rose EL, Singh A, Hussain S, Stagliano NE, Parry GC, Panicker S: TNT003, an inhibitor of the serine protease C1s, prevents complement activation induced by cold agglutinins. Blood. 2014 Jun 26;123(26):4015-22.
PubMed
Variant
0.1 mg
11-949-C100
In stock
203.50 USD
Variant
0.1 mg
11-949-C100
In stock
203.50 USD

Related products

-134%
Reg. statusCE IVD
ApplicationFC
100 ml
220.00 USD
-134%
Reg. statusCE IVD
ApplicationFC
100 ml
66.00 USD
-134%
Reg. statusRUO
ApplicationFC
100 ml
55.00 USD
-134%
CloneMOPC-21
Reg. statusRUO
0.1 mg
118.80 USD